Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants - 11/09/11
Abstract |
Objective: To determine the relative frequencies of the different genetic forms of severe combined immunodeficiency (SCID) and whether there are distinctive characteristics of the particular genotypes.
Study design: The demographic, genetic, and immunologic features of 108 infants with SCID who were treated consecutively at Duke University Medical Center were analyzed.
Results: Eighty-nine subjects were boys and 19 were girls; there were 84 white infants, 16 black infants, and 8 Hispanic infants. Forty-nine had X-linked SCID with mutations of common cytokine receptor gamma chain (γc ), 16 had adenosine deaminase (ADA) deficiency, 8 had Janus kinase 3 (Jak3) deficiency, 21 had unknown autosomal recessive mutations, 1 had reticular dysgenesis, 1 had cartilage hair hypoplasia, and 12 (all boys) had SCID of undetermined type. Deficiency of ADA caused the most profound lymphopenia; γc or Jak3 deficiency resulted in the most B cells and fewest natural killer (NK) cells; NK cells and function were highest in autosomal recessive and unknown types of SCID.
Conclusions: Different SCID genotypes are associated with distinctive lymphocyte characteristics. The presence of NK function in ADA-deficient, autosomal recessive, and unknown type SCIDs, and low NK function in a majority of γc and Jak3 SCIDs indicates that some molecular lesions affect T, B, and NK cells (γc and Jak3), others primarily T cells (ADA deficiency), and others just T and B cells. (J Pediatr 1997;130:378-87)
Le texte complet de cet article est disponible en PDF.Abbreviations : γc, ADA, HLA, Jak3, NK, SCID
Plan
| From the Departments of Pediatrics and Immunology, Duke University Medical Center, Durham, North Carolina, and the National Center for Human Genome Research, Bethesda, Maryland. |
|
| Supported by National Institutes of Health grant Nos. 5R37AI18613, U19 AI38550, and M01-RR-30. |
|
| Reprint requests: Rebecca H. Buckley, MD, Box 2898, Duke University Medical Center, Durham, NC 27710. |
|
| 0022-3476/97/$5.00 + 0 9/21/77548 |
Vol 130 - N° 3
P. 378-387 - mars 1997 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
